alexa Lymphoma|omicsgroup|journal Of Integrative Oncology

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Oncology 2020

Paris, France

Women's Health & Breast Cancer

New York, USA

Cancer Meet 2020

San Francisco, USA

Lymphoma Open Access Articles

Open access journal articles are essentially peer-reviewed and available for access through the directory of Open Access journals. OMICS Group International supports this system and provides access to 700+ peer-reviewed journals with no restrictions and thus promotes the Open Access movement with a view to promote scientific advancements. The research articles published in OMICS Group journals are immediately and permanently available online without charge. Hodgkin’s Lymphoma (HL) is a rare malignancy, with an incidence of about 2,4 per 100.000 per year. Estimated new cases and deaths from Hodgkin lymphoma in the United States in 2013 were: 9290 new cases and 1180 Deaths. More than 75% of all newly diagnosed patients with adult Hodgkin lymphoma can be cured with combination chemotherapy and/or radiation therapy. American National mortality has fallen more rapidly for adult HL than for any other malignancy over the last 5 decades. Clinical staging for patients with Hodgkin lymphoma includes a history, physical examination, laboratory studies (including sedimentation rate), and thoracic and abdominal/pelvic computerized tomographic (CT) scans.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on July, 2014